Stock Quote

ACOR (Common Stock) $ 32.44 +0.06 (+0.18%) Volume: 175,563 MORE October 21, 2014

Email Alerts

Un-subscribe from email alerts
Email Address *
Mailing Lists *


Firm Analyst
Aegis Capital Ram Selvaraju, Ph.D., MBA
Canaccord Genuity John Newman, Ph.D.
Citigroup Yaron Werber, M.D.
Cowen and Company Phil Nadeau, Ph.D.
FBR Capital Markets William Tanner, Ph.D.
ISI Group Mark Schoenebaum, M.D.
JPMorgan Geoff Meacham, Ph.D.
MKM Partners Jon LeCroy, M.D.
Piper Jaffray Co. David Amsellem
RBC Capital Markets Michael Yee
Robert W. Baird & Co. Christopher J. Raymond
Stifel Nicolaus Thomas Shrader

Acorda Therapeutics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Acorda Therapeutics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Acorda Therapeutics, Inc. or its management. Acorda Therapeutics, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.